Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
Researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to test whether the new targeted therapy Tarceva and the widely used chemotherapy drug Taxol are effectively killing tumor cells. They say that with further refinement, the test may make it possible to accurately assess whether patients are responding to these agents, as well as potentially others, within day...Drug Tarceva for End-stage Lung cancer
Patients with end-stage lung cancer who were given Tarceva lived longer than patients// given a placebo. Lung cancer is the most common cancer occurring both in men and women. Two studies were conducted by Canadian –led international research team with recruits from all over the world. The first study was conducted by Dr. Timothy Winton of the University of Alberta conducted his...Tarceva Found To Benefit Older Lung Cancer Patients
A new drug has shown promise in the clinical trials involving lung cancer patients and it has even been proposed to evaluate the drug as a frontline therapy for those with lung cancer. One of the significant problems // faced in the treatment regime in the elderly patients is the tolerability and side effects of the drugs currently used. The tyrosine kinase inhibitor erlotinib (Tarceva...Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
Roche Holding AG announced today that it has asked EU health authorities to re-examine data related to approving the pancreatic cancer treatment Tarceva.// The European Committee for Medicinal Products for Human Use (CHMP) had recently rejected the Tarceva application. "People with pancreatic cancer need new treatment options like Tarceva, which has been proven in clinical trials to s...